Scientists test 'Rechallenge' strategy to fight back when colorectal cancer returns
NCT ID NCT07178717
Summary
This study is testing whether restarting a specific two-drug combination can help control advanced colorectal cancer in patients who have a particular genetic mutation (BRAF V600E). The 25 participants have already been treated with similar drugs that initially worked for at least 6 months but eventually stopped controlling their cancer. Researchers want to see if giving the drugs again after a break can slow cancer growth for at least 4 more months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona, 08035, Spain
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.